Shackelford Pharma

Shackelford Pharma is an early stage biopharmaceutical company building on the pioneering work of Dr. Alan Shackelford and his treatment of over 25,000 patients using cannabis based therapies. The company is developing medicines targeting the endocannabinoid system of the human body and is dedicated to advancing evidence-based cannabinoid pharmaceuticals for unmet medical needs. Shackelford is focused on becoming a global leader in the development and commercialization of cannabinoid based medicine.